Showing results (1-10 of 434) with videos related to
Sort By:
Pageof 44
Fortschritte Der Neurologie-Psychiatrie|January 25, 2024
[Current and innovative Approaches to Multiple Sclerosis Therapy]Hernan Inojosa, Tjalf ZiemssenAutoimmunity Reviews|March 17, 2020
Clinical outcome measures in multiple sclerosis: A reviewHernan Inojosa, Dirk Schriefer, Tjalf ZiemssenFrontiers in Neurology|February 8, 2021
Should We Use Clinical Tools to Identify Disease Progression?Hernan Inojosa, Undine Proschmann, Katja Akgün, et al.Therapeutic Advances in Chronic Disease|January 24, 2022
The need for a strategic therapeutic approach: multiple sclerosis in checkHernan Inojosa, Undine Proschmann, Katja Akgün, et al.Frontiers in Neurology|May 3, 2021
Natalizumab Pharmacokinetics and -Dynamics and Serum Neurofilament in Patients With Multiple SclerosisUndine Proschmann, Hernan Inojosa, Katja Akgün, et al.Journal of Neurology|August 1, 2019
A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definitionHernan Inojosa, Undine Proschmann, Katja Akgün, et al.Fortschritte Der Neurologie-Psychiatrie|March 16, 2021
[MSProDiscuss - Development of a Digital Anamnesis Tool to Identify Disease Progression in Multiple Sclerosis]Hernan Inojosa, Katja Akgün, Katrin Haacke, et al.Frontiers in Neurology|March 17, 2020
Balance Testing in Multiple Sclerosis-Improving Neurological Assessment With Static Posturography?Hernan Inojosa, Dirk Schriefer, Antonia Klöditz, et al.Frontiers in Immunology|September 13, 2021
Drug and Neurofilament Levels in Serum and Breastmilk of Women With Multiple Sclerosis Exposed to Natalizumab During Pregnancy and LactationUndine Proschmann, Rocco Haase, Hernan Inojosa, et al.Frontiers in Digital Health|October 20, 2025
From implementation to discontinuation: multi-year experience with the multiple sclerosis performance test as a digital monitoring toolDirk Schriefer, Anja Dillenseger, Yassin Atta, et al.Pageof 44